Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Electromed Inc to Release Quarterly Earnings Report

Elaine Mendonca by Elaine Mendonca
February 12, 2024
in Breaking News
0
Healthcare-IT-and-tech
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Electromed, Inc. (ELMD) is scheduled to release its latest quarterly earnings report on February 13, 2024. Analysts predict that the company will announce an earnings per share (EPS) of $0.10.

In the previous quarter, Electromed fell short of the expected EPS by $0.08. Surprisingly, this setback was followed by a 2.09% rise in the share price the following day. It’s worth noting that the stock price of a company is not solely influenced by an earnings beat or miss, but also by the guidance or forecast provided.

Over the past 12 months, Electromed has accumulated a total revenue of $48.07M, indicating a 15.38% increase compared to the previous year. However, there has been a 9.46% decrease in revenue since the last quarter. The net income for the past 12 months stands at $3.17M.

If you require more comprehensive information regarding Electromed’s earnings, you can visit Nasdaq.com for detailed annual and quarterly earnings data. Moreover, Simply Wall St. offers a comprehensive stock overview, encompassing historical stock prices and performance for the company.

Analyzing Electromed, Inc. (ELMD) Stock Performance: Factors to Consider for Investors and Traders

On February 12, 2024, the stock performance of Electromed, Inc. (ELMD) was analyzed. It was found that the stock was trading in the middle of its 52-week range and below its 200-day simple moving average. The stock’s price dropped by $0.04 since the market last closed, representing a 0.42% decrease. The stock opened at $10.33, $0.05 lower than its previous close. Investors and traders should consider these factors when making decisions regarding ELMD stock.

Examining the Stock Performance of Electro Medical Devices (ELMD) on February 12, 2024: Insights into Financial Health and Recent Performance

On February 12, 2024, the stock performance of Electro Medical Devices (ELMD) is worth examining. By analyzing the data provided by CNN Money, we can gain insights into the company’s financial health and its recent performance.

Total revenue plays a crucial role in evaluating a company’s financial performance. In the past year, ELMD generated a total revenue of $48.07 million, which is an increase of 15.38% compared to the previous year. However, when compared to the previous quarter, the total revenue has decreased by 9.46%, standing at $12.32 million.

The net income of ELMD is another important metric to consider. Over the past year, the company reported a net income of $3.17 million, reflecting a significant increase of 37.35% compared to the previous year. However, in the first quarter of 2024, the net income dropped by 85.0% to $155.00 thousand.

Earnings per share (EPS) is a key indicator of a company’s profitability. ELMD reported an EPS of $0.36 in the past year, representing a growth of 38.42% compared to the previous year. However, in the first quarter of 2024, the EPS plummeted by 85.14% to $0.02.

Analyzing these numbers, it is clear that ELMD has experienced mixed results in terms of its financial performance. While the company managed to achieve a significant increase in total revenue and net income over the past year, the first quarter of 2024 saw a decline in both metrics. This decline is also reflected in the earnings per share, which experienced a sharp drop.

Investors and analysts will closely monitor these figures to understand the reasons behind the decline in the first quarter of 2024. It is important to consider various factors that may have contributed to this decline, including market conditions, competition, and internal factors within the company.

ELMD’s management team will likely be focused on implementing strategies to address the decrease in revenue and net income. They may explore opportunities to increase sales, reduce expenses, or improve operational efficiency to drive growth in the coming quarters.

Investors should exercise caution when considering ELMD as an investment option. It is crucial to conduct thorough research and analysis to understand the company’s overall financial health and its ability to navigate challenges in the industry.

In conclusion, the stock performance of ELMD on February 12, 2024, indicates a mixed financial performance. While the company experienced growth in total revenue, net income, and earnings per share over the past year, the first quarter of 2024 saw a decline in these metrics. Investors should closely monitor the company’s future performance and evaluate the strategies implemented by its management team to determine the potential for future growth.

Tags: ELMD
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Insurance Stock Exchange

Analyst Consensus and Price Target for Lincoln National Corporation LNC

Technology Data analytics stock Trading

WiMi Hologram Cloud Inc Unveils Revolutionary PBFT Algorithm for Blockchain Systems

Healthcare Services Stock Exchange

Renalytix PLCs Stock Soars After Exciting Announcement on CMS Draft LCD

Recommended

Upcoming FDA Advisory Committee Meeting for Imetelstat A Groundbreaking Treatment for Malignant Stem Cells

2 years ago
Portillo's Stock

Leadership Turmoil Sends Portillo’s Shares to New Low

2 months ago
Dine Brands Global Stock

Dine Brands Stock Faces Potential Downturn

1 month ago
Intel Stock

US Government Considers Taking Equity Stake in Intel

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Procter & Gamble Shares Approach a Critical Juncture

Trending

XRP Stock
Analysis

XRP Market Dynamics: Institutional Pause Meets Accumulation Surge

by Andreas Sommer
January 11, 2026
0

The XRP market is currently defined by a stark divergence in investor behavior. After a powerful rally...

Rocket Lab USA Stock

Rocket Lab’s Stock Momentum Continues Unabated in 2026

January 11, 2026
Eli Lilly Stock

Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

January 11, 2026
Alibaba Stock

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

January 11, 2026
Vulcan Energy Stock

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • XRP Market Dynamics: Institutional Pause Meets Accumulation Surge
  • Rocket Lab’s Stock Momentum Continues Unabated in 2026
  • Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com